1,2-Bis(3-methyl-1-phenyl-1H-pyrazol-5-yl)disulfane

ID: ALA2377172

PubChem CID: 9929673

Max Phase: Preclinical

Molecular Formula: C20H18N4S2

Molecular Weight: 378.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(SSc2cc(C)nn2-c2ccccc2)n(-c2ccccc2)n1

Standard InChI:  InChI=1S/C20H18N4S2/c1-15-13-19(23(21-15)17-9-5-3-6-10-17)25-26-20-14-16(2)22-24(20)18-11-7-4-8-12-18/h3-14H,1-2H3

Standard InChI Key:  NIJWTRSAOSNCDN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   12.4687  -12.4085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4718  -11.5811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7579  -11.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0406  -11.5783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0415  -12.4088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7559  -12.8195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7560  -13.6444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0890  -14.1299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3440  -14.9144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1695  -14.9137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4237  -14.1289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6549  -15.5807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3042  -13.8755    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.9691  -14.5411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9679  -15.3684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6827  -15.7812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3991  -15.3680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3963  -14.5374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6809  -14.1283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6790  -13.3034    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3449  -12.8165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0881  -12.0326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2626  -12.0351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0102  -12.8204    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7757  -11.3692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1303  -13.0691    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  7  1  0
  6  7  1  0
 10 12  1  0
  8 13  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 20  1  0
 19 20  1  0
 23 25  1  0
 21 26  1  0
 26 13  1  0
M  END

Associated Targets(Human)

FCGR1A Tclin High affinity immunoglobulin gamma Fc receptor I (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PBMC (10003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 378.53Molecular Weight (Monoisotopic): 378.0973AlogP: 5.47#Rotatable Bonds: 5
Polar Surface Area: 35.64Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.20CX LogP: 5.19CX LogD: 5.19
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.43Np Likeness Score: -0.90

References

1. Purohit MK, Scovell I, Neschadim A, Katsman Y, Branch DR, Kotra LP..  (2013)  Disulfide linked pyrazole derivatives inhibit phagocytosis of opsonized blood cells.,  23  (8): [PMID:23489619] [10.1016/j.bmcl.2013.02.064]
2. Purohit MK, Chakka SK, Scovell I, Neschadim A, Bello AM, Salum N, Katsman Y, Bareau MC, Branch DR, Kotra LP..  (2014)  Structure-activity relationships of pyrazole derivatives as potential therapeutics for immune thrombocytopenias.,  22  (9): [PMID:24685704] [10.1016/j.bmc.2014.03.016]

Source